Attenuation of changes in leukocyte surface markers and complement activation with heparin-coated cardiopulmonary bypass

Annals of Thoracic Surgery

Volumn 63, Issue 1, 1997, Pages 105-111

  Moen, Oddvar ^a   Høgåsen, Kolbjørn ^a   Fosse, Erik ^a   Dregelid, Einar ^a   Brockmeier, Vibeke ^a   Venge, Per ^a   Harboe, Morten ^a   Mollnes, Tom Eirik ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5; COMPLEMENT RECEPTOR; HEPARIN; INTEGRIN; L SELECTIN; PROTAMINE;

ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; LEUKOCYTE ACTIVATION; MALE; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ANTIGENS, SURFACE; BIOCOMPATIBLE MATERIALS; CARDIOPULMONARY BYPASS; COMPLEMENT ACTIVATION; CORONARY ARTERY BYPASS; FEMALE; HEPARIN; HUMANS; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; MALE; PLATELET COUNT;

EID: 0342981748     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(96)00743-6     Document Type: Article

References (25)

1. Van Oeveren W, Wildevuur CRH, Kazatchkine MD. Biocompatibility of extracorporeal circuits in heart surgery. Transfus Sci. 11:1990;5-33.
2. Korthuis RJ, Anderson DC, Granger DN. Role of neutrophil-endothelial cell adhesion in inflammatory disorders. J Crit Care. 9:1994;47-71.
3. Gillinov AM, DeValeria PA, Winkelstein JA, et al. Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypass. Ann Thorac Surg. 55:1993;619-624.
4. Elliott MJ, Finn AHR. Interaction between neutrophils and endothelium. Ann Thorac Surg. 56:1993;1503-1508.
5. Albeleda SM, Smith CW, Ward PA. Adhesion molecules and inflammatory injury. FASEB J. 8:1994;504-512.
6. McEver RP. Selectins novel receptors that mediate leukocyte adhesion during inflammation . Thromb Haemost. 65:1991;223-228.
7. Pemberton M, Anderson G, Vetvicka V, Justus DE, Ross GD. Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle. J Immunol. 150:1993;5104-5113.
8. Videm V, Mollnes TE, Garred P, et al. Biocompatibility of extracorporeal circulation. In vitro comparison of heparin-coated and uncoated oxygenator circuits. J Thorac Cardiovasc Surg. 101:1991;654-660.
9. Fosse E, Moen O, Johnson E, et al. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass. Ann Thorac Surg. 58:1994;472-477.
10. El Habbal MH, Carter H, Smith LJ, Elliott HMJ, Strobel S. Neutrophil activation in paediatric extracorporeal circuits effect of circulation and temperature variation . Cardiovasc Res. 29:1995;102-107.
11. Hill GE, Alonso A, Thiele GM, Robbins RA. Glucocorticoids blunt neutrophil CD11b surface glycoprotein upregulation during cardiopulmonary bypass in humans. Anesth Analg. 79:1994;23-27.
12. Gillinov AM, Bator JM, Zehr KJ, et al. Neutrophil adhesion molecule expression during cardiopulmonary bypass with bubble and membrane oxygenators. Ann Thorac Surg. 56:1993;847-853.
13. Finn A, Moat N, Rebuck N, et al. Changes in neutrophil CR3 and L-selectin expression and release of interleukin 8 and elastase in paediatric cardiopulmonary bypass. Agents Actions. 38:1993;44-46.
14. Redmond JM, Gillinov AM, Stuart RS, et al. Heparin-coated bypass circuits reduce pulmonary injury. Ann Thorac Surg. 56:1993;474-479.
15. Deppisch R, Schmitt V, Sommer J, Hänsch GM, Ritz E, Rauterberg EW. Fluid phase generation of terminal complement complex as a novel index of biocompatibility. Kidney Int. 37:1990;696-706.
16. Hack CE, Paardekooper JA, van Milligen F. Demonstration in human plasma of a form of C3 that has the conformation of "C3b-like C3." J Immunol. 144:1990;4249-4255.
17. Mollnes TE, Lea T, Frøland SS, et al. Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand J Immunol. 22:1985;197-202.
18. Olofsson T, Olsson I, Venge P, et al. Serum myeloperoxidase and lactoferrin in neutropenia. Scand J Haematol. 18:1977;73-80.
19. Van Beaumont W. Evaluation of hemoconcentration from hematocrit measurements. J Appl Physiol. 32:1972;712-713.
20. Øvrum E, Mollnes TE, Fosse E, et al. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits. J Thorac Cardiovasc Surg. 110:1995;1623-1632.
21. Moen O, Fosse E, Brockmeier V, et al. Disparity in blood activation by two different heparin-coated cardiopulmonary bypass systems. Ann Thorac Surg. 60:1995;1317-1323.
22. Mollnes TE, Videm V, Götze O, Harboe M, Oppermann M. Formation of C5a during cardiopulmonary bypass inhibition by precoating with heparin . Ann Thorac Surg. 52:1991;92-97.
23. Rinder CS, Rinder HM, Smith BR, et al. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. J Clin Invest. 96:1995;1564-1572.
24. Morgan BP. Complement membrane attack on nucleated cells resistance, recovery and non-lethal effects . Biochem J. 264:1989;1-14.
25. Kajita T, Hugli E. C5a-induced neutrophilia. Am J Pathol. 137:1990;467-477.